Neoadjuvant Ipilimumab/Nivolumab followed by adjuvant Nivolumab in locally advanced or oligometastatic melanoma

Home / Abstract / Neoadjuvant Ipilimumab/Nivolumab followed by adjuvant Nivolumab in locally advanced or oligometastatic melanoma